期刊文献+

肿瘤微环境及免疫调节系列研究指导乳腺癌精确治疗的临床实践 被引量:1

Interaction between Cancer Microenvironment with Molecular Immune Regulation: Evidences for Guiding Precise Treatments on Breast Cancer
下载PDF
导出
摘要 0引言尽管辅助治疗很大程度上改善了乳腺癌患者的预后,然而,来自循证医学的群体证据证明它不能使所有患者受益,因此治疗的个体化、精确化是目前乳腺癌治疗的重要方向。肿瘤发生发展是一个多因素、多个过程参与的复杂过程,具有精确而又复杂的调控机制。肿瘤微环境对肿瘤生长转移的重要调控作用已被众多学者关注并公认。
作者 任军
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2014年第11期1159-1162,共4页 Cancer Research on Prevention and Treatment
基金 国家"十二五"重大专项(2011ZX09302-001-02) 国家自然科学基金(39400159 39870787 30471995 81172534) 北京市科委2013年度科技创新基地培育与发展工程专项项目 美国Susan G Komen For Cure Foundation基金会项目
  • 相关文献

参考文献7

  • 1姜晗昉,宋国红,车利,邸立军,任军.口服小剂量环磷酰胺节拍疗法治疗晚期转移性乳腺癌23例临床分析[J].中国肿瘤临床,2011,38(2):104-107. 被引量:5
  • 2Guo-hong Song Jun Ren Lijun Di Jing Yu Jie Zhang Bin Shao Jun Jia Wei Sun.Decrease of Peripheral Blood CD8+/CD28- Suppressor T Cell Followed by Dentritic Cells Immunomodulation among Metastatic Breast Cancer Patients[J].Chinese Journal of Cancer Research,2010,22(4):310-315. 被引量:1
  • 3Gang Chen,Leisha A. Emens.Chemoimmunotherapy: reengineering tumor immunity[J].Cancer Immunology Immunotherapy.2013(2)
  • 4Ningning Dong,Jing Yu,Chaoying Wang,Xiaohui Zheng,Zheng Wang,Lijun Di,Guohong Song,Budong Zhu,Li Che,Jun Jia,Hanfang Jiang,Xinna Zhou,Xiaoli Wang,Jun Ren.Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetaxel plus capecitabine[J].Journal of Cancer Research and Clinical Oncology.2012(7)
  • 5Hanh K. Le,Laura Graham,Esther Cha,Johanna K. Morales,Masoud H. Manjili,Harry D. Bear.Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice[J].International Immunopharmacology.2009(7)
  • 6C. Marcela Diaz-Montero,Mohamed Labib Salem,Michael I. Nishimura,Elizabeth Garrett-Mayer,David J. Cole,Alberto J. Montero.Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy[J].Cancer Immunology Immunotherapy.2009(1)
  • 7Junliang Fu,Dongping Xu,Zhenwen Liu,Ming Shi,Ping Zhao,Baoyun Fu,Zheng Zhang,Huiyin Yang,Hui Zhang,Chunbao Zhou,Jinxia Yao,Lei Jin,Huifen Wang,Yongping Yang,Yang-Xing Fu,Fu-Sheng Wang.<ce:link locator="fx1"/> Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients[J].Gastroenterology.2007(7)

二级参考文献52

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 2Therasse P,Piccart M,van de Velde CJ,et al.The EORTC Breast Cancer Group:40 years of research contributing to improve breast cancer management[J].Eur J Cancer 2002;38(Suppl 4):S39-43.
  • 3Slamon DJ,Leyland-Jones B,Shak S,et al.Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2[J].N Engl J Med 2001;344:783-92.
  • 4Kiessling R,Wasserman K,Horiguchi S,et al.Tumor-induced immune dysfunction[J].Cancer Immunol Immunother 1999;48:353-62.
  • 5Melichar B,Touskova M,Solichova D,et al.CD4+T-lymphocytopenia and systemic immune activation in patients with primary and secondary liver tumours[J].Scand J Clin Lab Invest 2001:61:363-70.
  • 6Lissoni P,Brivio F,Ferrante R,et al.Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer[J].Int J Biol Markers 20.
  • 7Melichar B,Jandik P,Kreisek J,et al.Mitogeninduced lymphocyte proliferation and systemic immune activation in cancer patients[J].Tumori1996;82:218-20.
  • 8Okita R,Saeki T,Takashima S,et al.CD4+CD25+regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer[J].Oncol Rep 2005;14:1269-73.
  • 9Meloni F,Morosini M,Solari N,et al.Foxp3expressing CD4+CD25+and CD8+CD28-T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma[J].Human Immunology.
  • 10Shortman K,Caux C.Dendritic cell development:multiple pathways to nature's adjuvants[J].Stem Cells 1997;15:409-19.

同被引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部